Pancreatic Cancer Research

ResearcherSecond Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical UniversityNo recent work listed

Zhanxiong Xue

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-3310-4469; OpenAlex author ID A5063766440. Sources: OpenAlex.

Their work

Papers
4
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2014: 1 paper · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 1 paper

Papers 4

  1. High calpain-1 expression predicts a poor clinical outcome and contributes to tumor progression in pancreatic cancer patients. Co-author DOI 10.1007/s12094-018-02006-6↗
  2. High Rab11-FIP4 expression predicts poor prognosis and exhibits tumor promotion in pancreatic cancer. Co-author DOI 10.3892/ijo.2016.3828↗
  3. Latexin exhibits tumor-suppressor potential in pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/or.2015.4353↗
  4. Latexin inhibits the proliferation of CD133+ miapaca-2 pancreatic cancer stem-like cells. Co-author DOI 10.1186/1477-7819-12-404↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhenzhai Cai · 4 shared papers, 2014–2019 · strength 0.28
  2. Yun He · 2 shared papers, 2016–2017 · strength 0.12
  3. Yunfeng Shan · 2 shared papers, 2016–2017 · strength 0.12
  4. Ling Yu · 1 shared paper, 2019 · strength 0.11
  5. Xiang Zhou · 1 shared paper, 2014 · strength 0.04
  6. Zhiqiang Zheng · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.